A citation-based method for searching scientific literature

Laurence Legeai-Mallet. Endocr Dev 2016
Times Cited: 16







List of co-cited articles
93 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dwarfism and early death in mice lacking C-type natriuretic peptide.
H Chusho, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu,[...]. Proc Natl Acad Sci U S A 2001
330
56

Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Florence Lorget, Nabil Kaci, Jeff Peng, Catherine Benoist-Lasselin, Emilie Mugniery, Todd Oppeneer, Dan J Wendt, Sean M Bell, Sherry Bullens, Stuart Bunting,[...]. Am J Hum Genet 2012
104
50

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.
Daniel J Wendt, Melita Dvorak-Ewell, Sherry Bullens, Florence Lorget, Sean M Bell, Jeff Peng, Sianna Castillo, Mika Aoyagi-Scharber, Charles A O'Neill, Pavel Krejci,[...]. J Pharmacol Exp Ther 2015
57
43

Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
Akihiro Yasoda, Yasato Komatsu, Hideki Chusho, Takashi Miyazawa, Ami Ozasa, Masako Miura, Tatsuya Kurihara, Tomohiro Rogi, Shoji Tanaka, Michio Suda,[...]. Nat Med 2004
265
37

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Cynthia F Bartels, Hulya Bükülmez, Pius Padayatti, David K Rhee, Conny van Ravenswaaij-Arts, Richard M Pauli, Stefan Mundlos, David Chitayat, Ling-Yu Shih, Lihadh I Al-Gazali,[...]. Am J Hum Genet 2004
228
31

Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Akihiro Yasoda, Hidetomo Kitamura, Toshihito Fujii, Eri Kondo, Naoaki Murao, Masako Miura, Naotetsu Kanamoto, Yasato Komatsu, Hiroshi Arai, Kazuwa Nakao. Endocrinology 2009
79
31

Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
Pavel Krejci, Bernard Masri, Vincent Fontaine, Pertchoui B Mekikian, Maryann Weis, Herve Prats, William R Wilcox. J Cell Sci 2005
104
25

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.
Lincoln R Potter, Sarah Abbey-Hosch, Deborah M Dickey. Endocr Rev 2006
670
25

MECHANISMS IN ENDOCRINOLOGY: Novel genetic causes of short stature.
Jan M Wit, Wilma Oostdijk, Monique Losekoot, Hermine A van Duyvenvoorde, Claudia A L Ruivenkamp, Sarina G Kant. Eur J Endocrinol 2016
84
25

Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP.
V Mericq, J A Uyeda, K M Barnes, F De Luca, J Baron. Pediatr Res 2000
47
18

Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway.
A Yasoda, Y Ogawa, M Suda, N Tamura, K Mori, Y Sakuma, H Chusho, K Shiota, K Tanaka, K Nakao. J Biol Chem 1998
157
18

Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification.
Cristina C Teixeira, Hanga Agoston, Frank Beier. Dev Biol 2008
50
18

Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation.
Renata Bocciardi, Roberto Giorda, Jens Buttgereit, Stefania Gimelli, Maria Teresa Divizia, Silvana Beri, Silvio Garofalo, Sara Tavella, Margherita Lerone, Orsetta Zuffardi,[...]. Hum Mutat 2007
91
18

C-type natriuretic peptide (CNP) in rats and humans.
Y Komatsu, K Nakao, S Suga, Y Ogawa, M Mukoyama, H Arai, G Shirakami, K Hosoda, O Nakagawa, N Hama. Endocrinology 1991
306
18


Achondroplasia: Development, pathogenesis, and therapy.
David M Ornitz, Laurence Legeai-Mallet. Dev Dyn 2017
83
18

Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.
Naohisa Tamura, Lynda K Doolittle, Robert E Hammer, John M Shelton, James A Richardson, David L Garbers. Proc Natl Acad Sci U S A 2004
202
18

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature.
Sophie R Wang, Christina M Jacobsen, Heather Carmichael, Aaron B Edmund, Jerid W Robinson, Robert C Olney, Timothy C Miller, Jennifer E Moon, Veronica Mericq, Lincoln R Potter,[...]. Hum Mutat 2015
58
18

Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations.
Alexandra Gkourogianni, Melissa Andrew, Leah Tyzinski, Melissa Crocker, Jessica Douglas, Nancy Dunbar, Jan Fairchild, Mariana F A Funari, Karen E Heath, Alexander A L Jorge,[...]. J Clin Endocrinol Metab 2017
49
18

Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature.
Alfonso Hisado-Oliva, Alba Ruzafa-Martin, Lucia Sentchordi, Mariana F A Funari, Carolina Bezanilla-López, Marta Alonso-Bernáldez, Jimena Barraza-García, Maria Rodriguez-Zabala, Antonio M Lerario, Sara Benito-Sanz,[...]. Genet Med 2018
33
18

Role of the natriuretic peptide system in normal growth and growth disorders.
Gabriela A Vasques, Ivo J P Arnhold, Alexander A L Jorge. Horm Res Paediatr 2014
34
18

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting.
Claus H Gravholt, Niels H Andersen, Gerard S Conway, Olaf M Dekkers, Mitchell E Geffner, Karen O Klein, Angela E Lin, Nelly Mauras, Charmian A Quigley, Karen Rubin,[...]. Eur J Endocrinol 2017
363
18

C-type natriuretic peptide signalling drives homeostatic effects in human chondrocytes.
N J Peake, D L Bader, S Vessillier, M Ramachandran, D M Salter, A J Hobbs, T T Chowdhury. Biochem Biophys Res Commun 2015
5
40

Natriuretic peptide receptors regulate cytoprotective effects in a human ex vivo 3D/bioreactor model.
Nicholas Peake, Nyan Su, Manoj Ramachandran, Pramod Achan, Donald M Salter, Dan L Bader, Amie J Moyes, Adrian J Hobbs, Tina T Chowdhury. Arthritis Res Ther 2013
8
25

Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice.
Yasato Komatsu, Hideki Chusho, Naohisa Tamura, Akihiro Yasoda, Takashi Miyazawa, Michio Suda, Masako Miura, Yoshihiro Ogawa, Kazuwa Nakao. J Bone Miner Metab 2002
40
12


Biomechanical signals and the C-type natriuretic peptide counteract catabolic activities induced by IL-1β in chondrocyte/agarose constructs.
Manoj Ramachandran, Prim Achan, Donald M Salter, Dan L Bader, Tina T Chowdhury. Arthritis Res Ther 2011
14
14

Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis.
Hülya Bükülmez, Fozia Khan, Cynthia F Bartels, Shunichi Murakami, Adriana Ortiz-Lopez, Abdus Sattar, Tariq M Haqqi, Matthew L Warman. Arthritis Rheumatol 2014
18
12

Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function.
N J Peake, A J Hobbs, B Pingguan-Murphy, D M Salter, F Berenbaum, T T Chowdhury. Osteoarthritis Cartilage 2014
25
12

C-type natriuretic peptide in growth: a new paradigm.
Robert C Olney. Growth Horm IGF Res 2006
55
12

C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways.
Hanga Agoston, Sameena Khan, Claudine G James, J Ryan Gillespie, Rosa Serra, Lee-Anne Stanton, Frank Beier. BMC Dev Biol 2007
66
12

Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth.
Timothy C R Prickett, Adrienne M Lynn, Graham K Barrell, Brian A Darlow, Vicky A Cameron, Eric A Espiner, A Mark Richards, Timothy G Yandle. Pediatr Res 2005
56
12

The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.
Kazumasa Nakao, Kenji Osawa, Akihiro Yasoda, Shigeki Yamanaka, Toshihito Fujii, Eri Kondo, Noriaki Koyama, Naotetsu Kanamoto, Masako Miura, Koichiro Kuwahara,[...]. Sci Rep 2015
44
12


A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype.
Anne Moncla, Chantal Missirian, Pierre Cacciagli, Eve Balzamo, Laurence Legeai-Mallet, Jean-Luc Jouve, Brigitte Chabrol, Martine Le Merrer, Ghislaine Plessis, Laurent Villard,[...]. Hum Mutat 2007
62
12


Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
Takei Kake, Hidetomo Kitamura, Yuichiro Adachi, Tetsuro Yoshioka, Tomoyuki Watanabe, Hiroaki Matsushita, Toshihito Fujii, Eri Kondo, Takanori Tachibe, Yosuke Kawase,[...]. Am J Physiol Endocrinol Metab 2009
59
12

Advances in treatment of achondroplasia and osteoarthritis.
Kendra A Klag, William A Horton. Hum Mol Genet 2016
28
12

Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
Ami Ozasa, Yasato Komatsu, Akihiro Yasoda, Masako Miura, Yoko Sakuma, Yuko Nakatsuru, Hiroshi Arai, Nobuyuki Itoh, Kazuwa Nakao. Bone 2005
46
12

C-type natriuretic peptide.
C S Barr, P Rhodes, A D Struthers. Peptides 1996
102
12

Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.
Stéphanie Garcia, Béatrice Dirat, Thomas Tognacci, Nathalie Rochet, Xavier Mouska, Stéphanie Bonnafous, Stéphanie Patouraux, Albert Tran, Philippe Gual, Yannick Le Marchand-Brustel,[...]. Sci Transl Med 2013
57
12

Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
Rumi Hachiya, Yuko Ohashi, Yasutomi Kamei, Takayoshi Suganami, Hiroshi Mochizuki, Norimasa Mitsui, Masaaki Saitoh, Masako Sakuragi, Gen Nishimura, Hirofumi Ohashi,[...]. J Clin Endocrinol Metab 2007
48
12

Bioactivity and metabolism of C-type natriuretic peptide in normal man.
P J Hunt, A M Richards, E A Espiner, M G Nicholls, T G Yandle. J Clin Endocrinol Metab 1994
143
12


Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene.
Kohji Miura, Ok-Hwa Kim, Hey Ran Lee, Noriyuki Namba, Toshimi Michigami, Won Joon Yoo, In Ho Choi, Keiichi Ozono, Tae-Joon Cho. Am J Med Genet A 2014
47
12

cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells.
H Hagiwara, A Inoue, A Yamaguchi, S Yokose, M Furuya, S Tanaka, S Hirose. Am J Physiol 1996
90
12

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
Kohji Miura, Noriyuki Namba, Makoto Fujiwara, Yasuhisa Ohata, Hidekazu Ishida, Taichi Kitaoka, Takuo Kubota, Haruhiko Hirai, Chikahisa Higuchi, Noriyuki Tsumaki,[...]. PLoS One 2012
73
12


Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2.
Gabriela A Vasques, Alfonso Hisado-Oliva, Mariana F A Funari, Antonio M Lerario, Elisangela P S Quedas, Paulo Solberg, Karen E Heath, Alexander A L Jorge. J Pediatr Endocrinol Metab 2017
9
22

Growth hormone - past, present and future.
Michael B Ranke, Jan M Wit. Nat Rev Endocrinol 2018
85
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.